URGN – Urogen Pharma Ltd
Investors holding2
Combined shares101,051
Combined reported value$4.1M
URGN chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Polen Capital | 0.02 | Added 58.0% | 46,801 | $1.9M | Q3 2026 |
| Cathie Wood | 0.01 | Reduced 46.6% | 54,250 | $2.2M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Reduced 46.6% | 54,250 | 0.01 |
| Q3 2026 | Polen Capital | Added 58.0% | 46,801 | 0.01 |
| Q2 2026 | Polen Capital | New | 29,615 | 0.01 |
| Q2 2026 | Cathie Wood | Reduced 12.1% | 101,508 | 0.00 |
| Q1 2026 | Cathie Wood | Reduced 4.9% | 115,545 | 0.00 |
| Q4 2025 | Cathie Wood | Reduced 4.1% | 121,484 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Polen Capital | Added 58.0% | 46,801 | 0.01 |
| Q2 2026 | Polen Capital | New | 29,615 | 0.01 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Reduced 46.6% | 54,250 | 0.01 |
| Q2 2026 | Cathie Wood | Reduced 12.1% | 101,508 | 0.00 |
| Q1 2026 | Cathie Wood | Reduced 4.9% | 115,545 | 0.00 |
| Q4 2025 | Cathie Wood | Reduced 4.1% | 121,484 | 0.00 |
History
2 peakQ3 2026: 2 tracked investors
20172026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Polen Capital | 46.8K | 29.6K | – | – | – | – | – | – |
| Cathie Wood | 54.3K | 101.5K | 115.5K | 121.5K | 126.7K | 166.1K | 185.8K | 140.1K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).